Monoclonal antibody against MARCH1 preparation MAB-P3-00-001, 002, 003, 005 and MAB-P3-HC-001 (ambis #2254762)
Ended Purchase Order Awarded Last action
- Contract number
- 75N93025P00729
- Awardee
-
A&G Pharmaceutical, Inc. UEI SN6SWFABJXL1
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $16,900
Award facts
- Opportunity
-
- NOINIAID252254762 Solicitation number
- Contract value 100% obligated
- $16,900.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Columbia, MD 21045, USA
Award details come from SAM.gov/FPDS.
About this award
This is a firm-fixed price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to A&G Pharmaceutical, Inc. (doing business as Precision Antibody). The contract is for the preparation of monoclonal antibodies against the MARCH1 protein, with a ceiling value of $16,900.00 and a performance period through July 31, 2025.
A&G Pharmaceutical is a for-profit manufacturer of biological materials and research services, with a history of federal contracting primarily supporting biomedical research across areas like Alzheimer's disease, malaria, COVID-19, and oncology. The company holds a Blanket Purchase Agreement (BPA) with the NIH Office of Logistics and Acquisition Operations, valued at up to $100 million, which enables it to provide a range of biological materials, laboratory testing, and animal testing services to multiple NIH institutes and the Department of Agriculture's Agricultural Research Service. This specific contract does not have a set-aside designation, indicating open competition.
Quick answers
Who was awarded contract 75N93025P00729?
75N93025P00729 was awarded to A&G Pharmaceutical, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on March 25, 2025.
How much is contract 75N93025P00729 worth?
The government has obligated $16,900 on 75N93025P00729.
Was contract 75N93025P00729 competed?
The extent of competition for 75N93025P00729 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award